Local Average Treatment Effects
Summary
When treatment effects are heterogeneous, IV estimates the average causal effect on compliers — individuals whose treatment status is changed by the instrument. This is the LATE, introduced by Imbens and Angrist (1994).
The Four Types
With binary instrument and binary treatment :
| Type | when | when | Behavior |
|---|---|---|---|
| Compliers | 0 | 1 | Follow the instrument |
| Always-takers | 1 | 1 | Always treated |
| Never-takers | 0 | 0 | Never treated |
| Defiers | 1 | 0 | Do the opposite |
The LATE Theorem
Under monotonicity (no defiers) and exclusion restriction:
The Wald/IV estimand is the average treatment effect on compliers.
Why LATE Matters
- Different instruments identify different complier populations → different LATEs
- Example: twins and sex-composition instruments for family size give different estimates because they affect different women
- LATE ≠ ATE in general — the policy-relevant parameter depends on context
Characterizing Compliers
You can’t identify individual compliers, but you can describe them statistically:
- Compliance rate:
- Complier characteristics: compute using Bayes’ rule
See Also
- Instrumental Variables
- Regression Discontinuity Designs — fuzzy RD estimates LATE at the cutoff
- Differences-in-Differences — parallel-trends DiD is also a complier-flavored estimand under heterogeneous effects
- The Selection Problem — LATE is fundamentally a solution to the selection problem for non-compliant units
- Mostly Harmless Econometrics - Overview
- Hierarchical Models — Bayesian partial pooling as an alternative framework for treatment effect heterogeneity
- Regression and the CEF — the CEF provides the population target that LATE identifies in the complier subpopulation
- Bayesian Difference in Differences — DiD treatment effects under heterogeneous compliance connect to the LATE framework